stage 2 lung adenocarcinoma: biomarkers & treatment approaches - case-based panel discussions
Published 1 year ago • 395 plays • Length 15:26Download video MP4
Download video MP3
Similar videos
-
13:00
stage 3a node-positive lung adenocarcinoma with alk rearrangement - case based panel discussions
-
8:17
case based panel discussion - rapid progression adenocarcinoma high pd-l1 - how do you treat?
-
6:29
case based panel discussion nsclc – does a positive her2 mutation effect treatment decisions?
-
7:12
egfr mutated adenocarcinoma - case based panel discussions
-
5:31
biomarkers in nsclc - targeted therapies in lung cancer 2023
-
15:54
gracecast-075_lung-cancer_ccilc - optimal treatment for stage iiia n2 node-positive nsclc
-
5:06
case based panel discussion - egfr mutation and high pdl1 - what is the role of immunotherapy in tre
-
12:59
case based panel discussion - adv non squamous nsclc, low pd-l1 no mutation - best systemic therapy?
-
6:30
stage 3 squamous lung cancer with low pd-l1 - case based panel discussion
-
7:44
treatment for kras g12c mutated nsclc with high tumor mutational burden -case-based panel discussion
-
9:07
case based panel discussion - adv non squamous nsclc, high pd-l1, no mutation - optimal 1st line?
-
4:34
case based panel discussion - stage 3 nsclc treatment standard and the risk of potential pneumonitis
-
1:59:57
grace - global resource for advancing cancer education live stream
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
6:18
treating her2 exon-20 insertion nsclc with trastuzumab deruxtecan - case based panel discussion
-
3:45
case based panel discussion - egfr mutation and tagrisso - progression & the role of repeat biopsy
-
8:04
case based panel discussion 3.1 egfr mutation - chemotherapy and an egfr inhibitor concurrently or s
-
6:40:28
full video ondemand -targeted therapies patient forum 2022 - for those living with lung cancer